Montemor, Margie .

HRN: 23-38-82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2023
CEFUROXIME 500MG (TAB)
09/18/2023
09/24/2023
ORAL
500mg
BID
UTI In Pregnancy
Waiting Final Action 
09/20/2023
CEFUROXIME 1.5GM (VIAL)
09/20/2023
09/20/2023
IV
1.5gm
LD
Stat CS
Waiting Final Action 
09/20/2023
CEFUROXIME 1.5GM (VIAL)
09/20/2023
09/21/2023
IV
1.5 G
Q8 X 3 Doses
SP LTCS
Waiting Final Action 
09/20/2023
CEFUROXIME 1.5GM (VIAL)
09/20/2023
09/21/2023
IV
1.5 G
Q8 X 3 Doses
SP LTCS
Waiting Final Action 
09/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2023
09/21/2023
IV
500 Mg
Q8 X 3 Doses
SP Repeat LTCS
Waiting Final Action 
09/20/2023
METRONIDAZOLE 500MG (TAB)
09/21/2023
09/27/2023
PO
1 Tab
TID
SP Repeat LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: